DABT Topic_FDA FAQs New Drug Product Exclusivity Part 1

In this video DABT#Diplomat of American Board of Toxicology#ABT#American Board of Toxicology Aspirants and Toxicologists will learn about DABT Topic_FDA FAQs New Drug Product Exclusivity Part-1_New Drug Product Exclusivity_505(c)(3)(E) and 505(j)(5)(F)_NCE and "other significant changes" exclusivity_Drug Price Competition and Patent Term Restoration Act of 1984 (Hatch/Waxman Amendments)_Senator Hatch and Congressman Waxman _505(b)(2) Application_ANDA_Abbreviated New Drug Application (505)(j)_Reference Listed Drug (RLD_NDA-New Drug Application 505(b)(1)_Time periods of New Drug Product Exclusivity_5-year Period of Exclusivity_3-year Period of Exclusivity. IND_Adverse Drug Reaction    • DABT Topic_IND_Adverse Drug Reporting